Drug companies are ignoring health crisis in poor countries, Oxfam saysBMJ 2007; 335 doi: http://dx.doi.org/10.1136/bmj.39413.341701.DB (Published 29 November 2007) Cite this as: BMJ 2007;335:1111
- Adrian O'Dowd
The drug industry is “burying its head in the sand” when dealing with health in developing countries and denying poorer people access to life saving drugs, a report claims this week.
A critical report by the international agency Oxfam says that the drug industry is refusing to change the way it does business in poor countries, despite promising that it would, and is undermining its own future.
Oxfam's report looks at the world's top 12 drug companies, including their drug pricing policies, their record in developing drugs that are relevant to health care in poor countries, and their stance on protecting intellectual property rights.
The report says that the industry shows various …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial